To develop effective T cell therapeutics, you need to understand the underlying mechanisms behind powerful phenotypes. It’s now possible to do this with the most potent anti-tumor effector T cells — polyfunctional T cells. Using the OptoSeq™ Single Cell 3′ mRNA kit with the Multiplex Cytokine Assay and PrimeSeq™ software, the Opto™ Cell Therapy Development Workflow lets you: 

• Identify polyfunctional T cells by measuring the secretion of multiple cytokines 
• Perform differential gene expression analysis of recovered T cels to gain insight into their transcriptomes 
• Explore the genetic drivers and pathways behind the most promising T cells 

Want to learn more? 

• Explore our OptoSeq Single Cell 3′ mRNA kit application note 
• Watch the on-demand webinar, “Multi-omic Profiling of T Cells”

This story originally appeared in the Spring/Summer 2021 edition of BLI News. To read more, check out the latest edition.